Navigation Links
Jazz Pharmaceuticals Announces Participation in Two Investor Conferences
Date:11/26/2014

DUBLIN, Nov. 25, 2014 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will be webcasting its corporate presentations at two upcoming investor conferences. 

  • 31st NASDAQ Investor Program in London, UK on Tuesday, December 2, 2014 at 6:45 a.m. EST / 11:45 a.m. GMT. Iain McGill, senior vice president and head of EUSA International, will provide an overview of the company and a business and financial update.
  • 26th Annual Piper Jaffray Healthcare Conference in New York, NY on Tuesday, December 2, 2014 at 2:00 p.m. EST / 7:00 p.m. GMT. Bruce Cozadd, chairman and chief executive officer, will provide an overview of the company and a business and financial update.

A live audio webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

An archive of the webcast will be available for at least one week following the presentation on the Investors section of the company's website at www.jazzpharmaceuticals.com.

About Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing differentiated products that address unmet medical needs. The company has a diverse portfolio of products and/or product candidates in the areas of sleep, hematology/oncology, pain and psychiatry. The company's U.S. marketed products in these areas include: Xyrem® (sodium oxybate) oral solution, Erwinaze® (asparaginase Erwinia chrysanthemi), Prialt® (ziconotide) intrathecal infusion, Versacloz® (clozapine) oral suspension, FazaClo® (clozapine, USP) HD and FazaClo LD. Jazz Pharmaceuticals also has a number of products marketed outside the United States, including Erwinase® and Defitelio® (defibrotide). For more information, please visit www.jazzpharmaceuticals.com.


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/18/2018)... ... , ... Thailand sex change surgery market is the second biggest ... number of transgender populations opting for sex change surgical procedure, low cost of the ... in upcoming years. , Global sex change surgery market will surpass USD 968 Million ...
(Date:12/14/2018)... , ... December 14, 2018 , ... The Gypsy Nurse, ... release of its inaugural Travel Nurse Agency Evaluation results, available now on TheGypsyNurse.com ... to make informed decisions when it comes to choosing the agency that’s right for ...
(Date:12/14/2018)... (PRWEB) , ... December 14, 2018 , ... Jin Y. ... to the latest in periodontal care welcomes people with periodontal disease in ... he offers. LANAP provides comfortable, proven tissue regeneration and other solutions for the estimated ...
Breaking Medicine Technology:
(Date:12/13/2018)... ... December 13, 2018 , ... Dr. Daniel Careaga, prestigious plastic ... Haute Beauty Network, well known for their exclusivity, and luxurious lifestyle publication is ... addition to the Haute Living partnership. , Dr. Careaga has performed over ...
(Date:12/13/2018)... ... December 13, 2018 , ... ... regenerative and anti-aging practice. Dr. Haake is currently accepting new patients for hormone ... Family Medicine by the American Board of Osteopathic Medicine. A Diplomat of the ...
(Date:12/13/2018)... (PRWEB) , ... December 13, 2018 , ... ... Brad Swelstad, M.D., to the practice’s Virginia medical team, seeing patients at ... VA with a full range of state-of-the-art diagnostic and treatment options for female ...
(Date:12/13/2018)... ... December 13, 2018 , ... ... President of Consultant Engagement. Beth brings over 20 years of leadership experience in ... Beth is passionate about building strong teams and creating vibrant cultures of personal ...
(Date:12/13/2018)... ... December 13, 2018 , ... Allegheny General Hospital ... Memorial Hospital, all part of Allegheny Health Network (AHN), have been recognized as ... , Most Wired® is the industry-leading survey on IT adoption and innovation in ...
Breaking Medicine News(10 mins):